MDXG
MIMEDX GROUP, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.97
+0.51%Margins
Gross margin
77.3%
EBITDA margin
-5.6%
EBIT margin
-8.3%
Net margin
-6.3%
FCF margin
6.7%
-9.1%
Return on equity
-7.3%
Return on assets
-11.9%
Return on invested capital
1.11x
Asset turnover
$20.7M
Cash from operations
$0.83
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026